Skip to main content

Specialty Pharmacy

AbbVie, University of Chicago team on cancer innovation efforts
CHICAGO — AbbVie and the University of Chicago announced this week a new five-year collaboration to advance oncology medical research and improve the pace of discovery for both organizations.
FDA approves Boehringer Ingelheim’s Gilotrif for squamous cell lung cancer
SILVER SPRING, Md. — The Food and Drug Administration recently approved Boehringer Ingelheim Pharmaceuticals’ Gilotrif, a treatment for patients with advanced squamous cell carcinoma of the lung whose illness has progressed following platinum-based chemotherapy.

The once-daily oral therapy had previously been approved as a first-line treatment for specific types of non-small cell lung cancer.

X

This ad will auto-close in 10 seconds